What a honor to coordinate a 10-million euros project on locally advanced pancreatic cancer with @amsterdamumc and @surgery_hps, funded by the @HorizonEU! @PALACROSeu will establish harmonised standards and expand access to specialised pancreatic surgery. https://t.co/CoqaIUIDDq
Come to our clinician meets the basic scientist corner close to the Bosphorus Hall to solve your doubts‼️
Great initiative from the Public Affairs Committee🤩
Germiline testing (41-genes) of 500 individuals at high-risk for familial PDAC enrolled in a @AISP_Pancreas national program, led by @Totuccio1983. 44 (8.8%) carried at least 1 pathogenic variant. However, PDAC also seen in mutation-negative subjects.
https://t.co/9LgMAVYLkb
💦Postoperative collections after left pancreatectomy are an under appreciated issue occurring in >50% of patients, although only 15% are clinically relevant. A standardized definition is needed, particularly in light of the steady uptake of no-drain policies!
Today is World Pancreatic Cancer Day 💜and the @EurPancClub wanted to give patients the opportunity to raise their voice🔊🔊🔊 with this campaign
#VoicesofPancreaticCancer
Voice of pancreatic cancer for World Pancreatic Cancer Day 2025.
On World Pancreatic Cancer day 💜 the EPC wants to raise our patient’s voices‼️‼️
More testimonials here👇🏼👇🏼👇🏼
https://t.co/KMMO8gSaRi
Surgery-specific antimicrobial stewardship programs with personalized antibiotic strategies represent a promising approach to minimizing infection risk while combating antibiotic resistance in procedures such as pancreatoduodenectomy. https://t.co/KPpyjpcFYO
A pancreatic surgery antimicrobial stewardship program with preoperative screening for MDR bacteria to guide antibiotic prophylaxis reduced the risk of SSIs following pancreatoduodenectomy. https://t.co/KPpyjpc89g
Our group at the @EurPancClub meeting in Düsseldorf, (with our 🇫🇷 friend @NelsonDusetti!) perfectly organized by @IEspositoPATH. The house of European Pancreatology🇪🇺, where basic science, molecular biology, pathology, gastroenterology, surgery, and oncology come together🤝.
📢 Join us at #EPC2025 for the session:
“Pancreatic Cancer: Call to Prevention and Screening – Can We Do More?”
🗓 July 2 | ⏰ 12:45–13:45 CEST
📍 Düsseldorf, Auditorium 13B
🔗:https://t.co/ldstHe8BVy
🌍 JOIN US AND DO MORE!
my_ueg UEGJournal
Just published in *The Journal of Pathology* our new investigation on mucinous cystic neoplasms (MCN) and simple mucinous cysts (SMC) of the pancreas (a new precursor of pancreatic cancer!)
https://t.co/ZWJDreukbD
🚨New publication! 🚨
A new method for evaluating CA19-9 during neoadjuvant therapy, and its role in predicting overall and disease-free survival in BR-PC. A way towards personalised prognostication! 💜💪🏻🙏🏼
https://t.co/h42NIbKeak
Today 1st patient with locally advanced PDAC implanted in Verona with 32P microparticles. This form of brachytherapy is being investigated in a RCT (TRIPP_FFX) where patients receive induction mFOLFIRINOX with or without P32 microparticles @OncoSil_Medical@CrinoStefano